AstraZeneca Welcomes Provisional Consent For COVID-19 Vaccine In New Zealand

Published: Thu 29 Jul 2021 12:25 PM
AstraZeneca welcomes the announcement made by the New Zealand Government and regulatory authority Medsafe today that COVID-19 Vaccine AstraZeneca has been granted provisional consent for individuals 18 years and older.
New Zealand secured 7.6 million doses of AstraZeneca’s COVID-19 vaccine, enough for 3.8 million people, through an advance purchase agreement late last year.
Country President of AstraZeneca Australia and New Zealand, Liz Chatwin, said: “We are pleased to receive this consent from New Zealand’s regulatory body today.
“In less than 12 months, more than 750 million doses of the Oxford-AstraZeneca COVID-19 vaccine have been released for supply to more than 170 countries. Our vaccine continues to be an important tool in overcoming the COVID-19 global health emergency, underpinned by our commitment to provide broad and equitable access, at no profit during the pandemic.”
AstraZeneca (LSE/STO/NYSE: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
For more information, please visit and

Next in Lifestyle

Emerald Fenenell's 'Promising Young Woman'
By: howard davis
Jill Trevelyan's 'Rita Angus, An Artist's Life'
By: Howard Davis
The Back of the Painting
By: howard davis
Black Panthers on the Prowl
By: Howard Davis
Controlling the High Ground
By: Howard Davis
Dryzabone - Robert Conolly's 'The Dry'
By: Howard Davis
Hit The Road, Jack - Chloé Zhao's 'Nomadland'
By: Howard Davis
View as: DESKTOP | MOBILE © Scoop Media